Truvada/Kaletra HIV PEP combination is safe and effective with a low rate of discontinuations
Aidsmap rated 'excellent' in a survey of HIV internet resources
Loss to follow-up high in South African public sector ARV programmes
Where is HIV vaccine research heading?
